|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
6
|
Zenith Epigenetics
|
Sep 05, 2018 03:50PM
|
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
1
|
Zenith Epigenetics
|
Sep 01, 2018 01:23PM
|
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 31, 2018 03:45PM
|
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 30, 2018 03:01PM
|
|
My Current Wish List
|
3
|
Resverlogix Corp.
|
Aug 27, 2018 03:44PM
|
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:53PM
|
|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:39PM
|
|
What If - Uses of Apabetalone
|
2
|
Resverlogix Corp.
|
Aug 11, 2018 02:52PM
|
|
Re: Things are happening
|
|
Resverlogix Corp.
|
Aug 03, 2018 04:28PM
|
|
Re: The beginning of the end game
|
6
|
Resverlogix Corp.
|
Aug 02, 2018 06:44PM
|
|
Re: Momentum
|
1
|
Resverlogix Corp.
|
Jul 31, 2018 04:19PM
|
|
Momentum
|
5
|
Resverlogix Corp.
|
Jul 30, 2018 05:16PM
|
|
Re: DMSB,,early August,,as per jk!
|
2
|
Resverlogix Corp.
|
Jul 26, 2018 03:02PM
|
|
Re: AAIC and MD&A
|
|
Resverlogix Corp.
|
Jul 24, 2018 12:37PM
|
|
Re: DSMB 7th review??
|
4
|
Resverlogix Corp.
|
Jul 20, 2018 04:40PM
|
|
Epigenetic Primer
|
5
|
Resverlogix Corp.
|
Jul 19, 2018 03:36PM
|
|
Re: The way the trading has gone the past few days....
|
6
|
Resverlogix Corp.
|
Jul 19, 2018 02:37PM
|
|
Inflammation
|
3
|
Resverlogix Corp.
|
Jul 17, 2018 04:20PM
|
|
Re: More options exercised, this time by Ewelina Kulikowski
|
4
|
Resverlogix Corp.
|
Jul 13, 2018 01:14PM
|
|
RVX share price
|
5
|
Resverlogix Corp.
|
Jul 08, 2018 02:25PM
|
